Tanyuansu Disinfectant
NDC Package 78315-201-17

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tanyuansu Disinfectant is a . Marketed by Qinhe (hubei) Biotechnology Co., Ltd., this product is identified by NDC 78315-201 and is authorized under FDA application M014.

Identification & Billing

NDC Package Code
78315-201-17
Package Description
140 BOTTLE, PUMP in 1 CARTON / 100 mL in 1 BOTTLE, PUMP (78315-201-01)
Product Code
78315-201
11-Digit Billing Format
78315020117

Clinical Specifications

Proprietary Name
Tanyuansu Disinfectant
Dosage Form
-

Regulatory & Marketing

Labeler Name
Qinhe (hubei) Biotechnology Co., Ltd.
FDA Application #
M014
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-01-2020
End Marketing Date
11-21-2023
Listing Expiration
11-21-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 78315-201-17 identifies a specific commercial package of 140 bottle, pump in 1 carton / 100 ml in 1 bottle, pump (78315-201-01) of Tanyuansu Disinfectant, labeled by Qinhe (hubei) Biotechnology Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Qinhe (hubei) Biotechnology Co., Ltd. on June 01, 2020. The current certification is valid through November 21, 2023.

How is this Qinhe (hubei) Biotechnology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 78315020117. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
78315-201-17
11-Digit CMS (5-4-2)
78315-0201-17

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.